Regulation of phosphoprotein p18 in leukemic cells. Cell cycle regulated phosphorylation by p34cdc2 kinase.

PubWeight™: 1.20‹?› | Rank: Top 10%

🔗 View Article (PMID 8144611)

Published in J Biol Chem on April 08, 1994

Authors

X N Luo1, B Mookerjee, A Ferrari, S Mistry, G F Atweh

Author Affiliations

1: Department of Medicine, Mount Sinai School of Medicine, New York, New York 10029.

Articles citing this

Oncoprotein 18 is a phosphorylation-responsive regulator of microtubule dynamics. EMBO J (1996) 2.15

Regulation of microtubule dynamics by Ca2+/calmodulin-dependent kinase IV/Gr-dependent phosphorylation of oncoprotein 18. Mol Cell Biol (1997) 1.53

Regulation of Op18 during spindle assembly in Xenopus egg extracts. J Cell Biol (2001) 1.46

Overexpression of stathmin1 in the diffuse type of gastric cancer and its roles in proliferation and migration of gastric cancer cells. Br J Cancer (2010) 1.46

Overexpression of stathmin in breast carcinomas points out to highly proliferative tumours. Br J Cancer (2000) 1.39

Correlation of oncoprotein 18/stathmin expression in human breast cancer with established prognostic factors. Br J Cancer (2000) 1.35

Stathmin interaction with a putative kinase and coiled-coil-forming protein domains. Proc Natl Acad Sci U S A (1995) 1.31

Overexpression of the stathmin gene in a subset of human breast cancer. Br J Cancer (1998) 1.09

Stathmin-deficient mice develop an age-dependent axonopathy of the central and peripheral nervous systems. Am J Pathol (2002) 1.02

Differential proteomic analysis of a highly metastatic variant of human breast cancer cells using two-dimensional differential gel electrophoresis. J Cancer Res Clin Oncol (2010) 1.02

Inhibiting proliferation and enhancing chemosensitivity to taxanes in osteosarcoma cells by RNA interference-mediated downregulation of stathmin expression. Mol Med (2007) 1.01

Role for protein phosphatases in the cell-cycle-regulated phosphorylation of stathmin. Biochem J (1998) 1.00

Analysis of gene expression identifies candidate molecular markers in nasopharyngeal carcinoma using microdissection and cDNA microarray. J Cancer Res Clin Oncol (2006) 0.99

The phosphoprotein stathmin is essential for nerve growth factor-stimulated differentiation. J Cell Biol (1996) 0.95

Regulation of microtubule dynamics through phosphorylation on stathmin by Epstein-Barr virus kinase BGLF4. J Biol Chem (2010) 0.91

Stathmin/Op18 phosphorylation is regulated by microtubule assembly. Mol Biol Cell (2001) 0.90

Expression of stathmin/op18 as a significant prognostic factor for cervical carcinoma patients. J Cancer Res Clin Oncol (2008) 0.89

Aneugenic activity of Op18/stathmin is potentiated by the somatic Q18-->e mutation in leukemic cells. Mol Biol Cell (2006) 0.89

Lentiviral-mediated RNA interference targeting stathmin1 gene in human gastric cancer cells inhibits proliferation in vitro and tumor growth in vivo. J Transl Med (2013) 0.86

Stathmin is involved in S100A4-mediated regulation of cell cycle progression. Clin Exp Metastasis (1999) 0.84

c-Jun N-terminal kinase phosphorylation of stathmin confers protection against cellular stress. J Biol Chem (2010) 0.81

The cytotoxic effect of memantine and its effect on cytoskeletal proteins expression in metastatic breast cancer cell line. Iran J Basic Med Sci (2017) 0.75

Thyroid hormone suppresses expression of stathmin and associated tumor growth in hepatocellular carcinoma. Sci Rep (2016) 0.75

Articles by these authors

(truncated to the top 100)

Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. Genes Dev (2000) 5.16

Analysis of vertebrate SCL loci identifies conserved enhancers. Nat Biotechnol (2000) 4.01

The DNA sequence and biological annotation of human chromosome 1. Nature (2006) 2.42

Effects of blood-pressure measurement by the doctor on patient's blood pressure and heart rate. Lancet (1983) 2.18

A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost (2010) 2.08

Renal distal tubular handling of sodium in central fluid volume homoeostasis in preascitic cirrhosis. Gut (1999) 2.07

Regulation of death receptor expression and TRAIL/Apo2L-induced apoptosis by NF-kappaB. Nat Cell Biol (2001) 1.83

Blood pressure and heart rate variabilities in normotensive and hypertensive human beings. Circ Res (1983) 1.74

Role of ultrasonography in detecting mammographically occult breast carcinoma in women with dense breasts. Radiol Med (2006) 1.74

Regulation of transferrin, transferrin receptor, and ferritin genes in human duodenum. Gastroenterology (1992) 1.73

Automated hemagglutination assays. Ann N Y Acad Sci (1965) 1.68

Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60

Protocadherin 19 mutations in girls with infantile-onset epilepsy. Neurology (2010) 1.59

p53-mediated repression of nuclear factor-kappaB RelA via the transcriptional integrator p300. Cancer Res (1998) 1.51

Treatment with a gonadotrophin releasing hormone agonist before hysterectomy for leiomyomas: results of a multicentre, randomised controlled trial. Br J Obstet Gynaecol (1998) 1.43

Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41

Percutaneous transhepatic sphincterotomy--a report on 3 cases. Endoscopy (1991) 1.41

A morphometric study of liver cell dysplasia. Hum Pathol (1988) 1.40

Mice overexpressing chemokine ligand 2 (CCL2) in astrocytes display enhanced nociceptive responses. Neuroscience (2007) 1.40

Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7  TeV. Phys Rev Lett (2011) 1.39

The level of urokinase-type plasminogen activator receptor is increased in serum of ovarian cancer patients. Cancer Res (1998) 1.38

Low-dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive fibromatosis. Cancer (2001) 1.36

Terrestrial gamma-ray flashes as powerful particle accelerators. Phys Rev Lett (2011) 1.35

Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34

Assessment of portal hypertension by endoscopic ultrasonography. Gastrointest Endosc (1990) 1.34

Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32

Immunohistochemical study of epithelial cell proliferation in hyperplastic polyps, adenomas, and adenocarcinomas of the large bowel. Gastroenterology (1988) 1.32

Colorectal adenomas containing invasive carcinoma. Pathologic assessment of lymph node metastatic potential. Cancer (1989) 1.30

Percutaneous endoscopic gastrostomy: a long-term follow-up. Nutrition (1997) 1.29

Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27

Clinically equivocal melanocytic skin lesions with features of regression: a dermoscopic-pathological study. Br J Dermatol (2004) 1.27

Development of functionalized superparamagnetic iron oxide nanoparticles for interaction with human cancer cells. Biomaterials (2005) 1.26

A phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancer. Ann Oncol (2011) 1.23

Ectopic bone formation following low friction arthroplasty of the hip. Clin Orthop Relat Res (1977) 1.22

Mechanisms modifying glucose oxidation in diabetes mellitus. Diabetologia (1994) 1.22

Emergency laparoscopic splenectomy for "wandering" (pelvic) spleen: case report and review of the literature on laparoscopic approach to splenic diseases. Surg Endosc (2002) 1.20

The variable-pressure neck-chamber method for studying the carotid baroreflex in man. Clin Sci Mol Med (1977) 1.20

Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19

Analysis of short-term oscillations of R-R and arterial pressure in conscious dogs. Am J Physiol (1990) 1.18

Risk for spontaneous preterm delivery by combined body mass index and gestational weight gain patterns. Acta Obstet Gynecol Scand (1998) 1.18

Result of liver resection as treatment for metastases from noncolorectal cancer. J Surg Oncol (2000) 1.18

Interaction between lymphocytes and cultured high endothelial cells: an in vitro model of lymphocyte migration across high endothelial venule endothelium. Eur J Immunol (1988) 1.15

Search for a supersymmetric partner to the top quark in final states with jets and missing transverse momentum at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.13

Discovery of powerful gamma-ray flares from the Crab Nebula. Science (2011) 1.13

Effects of stathmin inhibition on the mitotic spindle. J Cell Sci (2001) 1.13

Changes in pharyngeal corticobulbar excitability and swallowing behavior after oral stimulation. Am J Physiol Gastrointest Liver Physiol (2003) 1.12

Molecular cloning of a novel human leukemia-associated gene. Evidence of conservation in animal species. J Biol Chem (1989) 1.12

Alveolar soft part sarcoma in children and adolescents: A report from the Soft-Tissue Sarcoma Italian Cooperative Group. Ann Oncol (2000) 1.12

Value of endoscopic ultrasonography in the management of portal hypertension. Endoscopy (1992) 1.12

Antisense RNA inhibition of phosphoprotein p18 expression abrogates the transformed phenotype of leukemic cells. Cancer Res (1996) 1.11

Visualization of in vivo direct interaction between HIV-1 TAT and human cyclin T1 in specific subcellular compartments by fluorescence resonance energy transfer. J Biol Chem (2001) 1.10

Presence of urokinase-type plasminogen activator receptor in urine of cancer patients and its possible clinical relevance. Lab Invest (1999) 1.10

Intracranial solitary extraskeletal plasmacytoma resembling meningioma. Arch Neurol (1982) 1.10

Intermittent treatment with mesalazine in the prevention of diverticulitis recurrence: a randomised multicentre pilot double-blind placebo-controlled study of 24-month duration. Int J Colorectal Dis (2013) 1.10

Beta-thalassemia resulting from a single nucleotide substitution in an acceptor splice site. Nucleic Acids Res (1985) 1.09

Plasma paraoxonase, health, inflammatory conditions, and liver function in transition dairy cows. J Dairy Sci (2007) 1.09

Palliative care for intestinal obstruction in recurrent ovarian cancer: a multivariate analysis. Int J Gynecol Cancer (2005) 1.07

Search for tb resonances in proton-proton collisions at √s=7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.07

Hormone status selects for spontaneous somatic androgen receptor variants that demonstrate specific ligand and cofactor dependent activities in autochthonous prostate cancer. J Biol Chem (2000) 1.07

Control of blood pressure by carotid sinus baroreceptors in human beings. Am J Cardiol (1979) 1.06

Sclerosing stromal tumor of the ovary. Report of eight cases and review of the literature. Eur J Obstet Gynecol Reprod Biol (1998) 1.06

[Radiofrequency transcatheter ablation of anomalous left atrioventricular pathways: the role of the transseptal approach]. G Ital Cardiol (1992) 1.06

Dermoscopic diagnosis by a trained clinician vs. a clinician with minimal dermoscopy training vs. computer-aided diagnosis of 341 pigmented skin lesions: a comparative study. Br J Dermatol (2002) 1.05

Non-variceal upper gastrointestinal bleeding and Forrest's classification: diagnostic agreement between endoscopists from the same area. Endoscopy (1998) 1.05

Circulatory reflexes from carotid and extracarotid baroreceptor areas in man. Circ Res (1977) 1.05

Search for a light Higgs boson decaying to long-lived weakly interacting particles in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.05

Clinical CT-based calculations of dose and positron emitter distributions in proton therapy using the FLUKA Monte Carlo code. Phys Med Biol (2007) 1.04

Elevated serum progesterone on the day of HCG administration in IVF is associated with a higher pregnancy rate in polycystic ovary syndrome. Hum Reprod (1999) 1.04

Randomized, double blind placebo-controlled trial: effects of myo-inositol on ovarian function and metabolic factors in women with PCOS. Eur Rev Med Pharmacol Sci (2007) 1.04

Sequential intensified chemotherapy with stem cell rescue for children and adolescents with desmoplastic small round-cell tumor. Bone Marrow Transplant (2009) 1.03

Sympathovagal interaction during mental stress. A study using spectral analysis of heart rate variability in healthy control subjects and patients with a prior myocardial infarction. Circulation (1991) 1.03

Modification of arterial baroreflexes by captopril in essential hypertension. Am J Cardiol (1982) 1.02

A deep intronic mutation in CDKN2A is associated with disease in a subset of melanoma pedigrees. Hum Mol Genet (2001) 1.01

Teledermoscopy--results of a multicentre study on 43 pigmented skin lesions. J Telemed Telecare (2000) 1.01

Role for protein phosphatases in the cell-cycle-regulated phosphorylation of stathmin. Biochem J (1998) 1.00

A new mutation in IVS-1 of the human beta globin gene causing beta thalassemia due to abnormal splicing. Blood (1987) 1.00

Blood pressure variability in man: its relation to high blood pressure, age and baroreflex sensitivity. Clin Sci (Lond) (1980) 1.00

Endoscopic sphincterotomy for stones by experts is safe, even in younger patients with normal ducts. Ann Surg (1998) 0.99

Search for supersymmetry in events with three leptons and missing transverse momentum in √[s]=7 TeV pp collisions with the ATLAS detector. Phys Rev Lett (2012) 0.99

A prospective study of the ability of three endoscopic classifications to predict hemorrhage from esophageal varices. Gastrointest Endosc (1992) 0.99

Effect of copolymer-1 on serial gadolinium-enhanced MRI in relapsing remitting multiple sclerosis. Neurology (1998) 0.99

Instrument-, age- and site-dependent variations of dermoscopic patterns of congenital melanocytic naevi: a multicentre study. Br J Dermatol (2006) 0.97

Type of estrogen receptor determines response to antiestrogen therapy. Cancer Res (1996) 0.97

Taxol and anti-stathmin therapy: a synergistic combination that targets the mitotic spindle. Cancer Res (2000) 0.97

[A cardiac embolic stroke due to malposition of the pacemaker lead in the left ventricle. A case report]. Ital Heart J Suppl (2000) 0.97

Different isoforms of the B-cell mutator activation-induced cytidine deaminase are aberrantly expressed in BCR-ABL1-positive acute lymphoblastic leukemia patients. Leukemia (2009) 0.96

Review article: chronic hepatitis C--natural history and cofactors. Aliment Pharmacol Ther (2005) 0.96

Delayed hypersensitivity in vitro using human peripheral leucocytes. Transplantation (1969) 0.96

Guillotine needle biopsy as a supplement to endosonography in the diagnosis of gastric submucosal tumors. Endoscopy (1991) 0.95

The presence of methanobacteria in human subgingival plaque. J Clin Periodontol (1987) 0.95

Cabergoline influences ovarian stimulation in hyperprolactinaemic patients with polycystic ovary syndrome. Hum Reprod (2001) 0.95

Plasma glutathione level in paracetamol daily abuser patients. Changes in plasma cysteine and thiol groups after reduced glutathione administration. Toxicol Lett (1992) 0.95

Intravenous lipid emulsions are the major determinant of coagulase-negative staphylococcal bacteremia in very low birth weight newborns. Pediatr Infect Dis J (1998) 0.95

Hashimoto's disease in a papillary carcinoma of the thyroid originating in a teratoma of the ovary (malignant struma ovarii). Gynecol Endocrinol (1998) 0.95

Human dental pulp stem cells produce mineralized matrix in 2D and 3D cultures. Eur J Histochem (2010) 0.94

IDH2 somatic mutations in chronic myeloid leukemia patients in blast crisis. Leukemia (2010) 0.94

Risk factors in surgery. J Chemother (2001) 0.94

Profiling of drug-metabolizing enzymes/transporters in CD33+ acute myeloid leukemia patients treated with Gemtuzumab-Ozogamicin and Fludarabine, Cytarabine and Idarubicin. Pharmacogenomics J (2012) 0.94

G-cell counts in antral endoscopic biopsies by immunofluorescence. Scand J Gastroenterol (1977) 0.93

Application of automated analysis to the study of bacterial growth. I. The instrumental system. Ann N Y Acad Sci (1965) 0.93